Bacteriophage therapy
Showing 1 - 25 of >10,000
Diabetic Foot Infection Trial (TP-102, Placebo)
Not yet recruiting
- Diabetic Foot Infection
- TP-102
- Placebo
- (no location specified)
Jul 6, 2023
Bacteriophage Therapy of Difficult-to-treat Infections
Completed
- Bacterial Infections
- Bacteriophage therapy
- (no location specified)
Aug 10, 2022
Urinary Tract Infection Bacterial Trial in United States (Bacteriophage Therapy)
Active, not recruiting
- Urinary Tract Infection Bacterial
- Bacteriophage Therapy
-
Doral, Florida
- +7 more
Jan 25, 2023
Prosthetic Joint Infection Trial (Bacteriophage, Placebo)
Not yet recruiting
- Prosthetic Joint Infection
- Bacteriophage
- Placebo
- (no location specified)
Feb 25, 2022
Bacteriophage Therapy Trial in Rochester
Enrolling by invitation
- Bacteriophage Therapy
-
Rochester, MinnesotaMayo Clinic Rochester
May 3, 2022
Prosthetic Joint Infection, Bacterial Infections Trial (Phage Therapy)
Not yet recruiting
- Prosthetic Joint Infection
- Bacterial Infections
- Phage Therapy
- (no location specified)
Mar 8, 2022
Cystic Fibrosis Trial in New Haven (Standard Dose YPT-01, Placebo)
Recruiting
- Cystic Fibrosis
- Standard Dose YPT-01
- Placebo
-
New Haven, ConnecticutYale New Haven Hospital
Oct 6, 2021
Prosthetic Joint Infection Trial in Rochester (Phage Therapy, Two-Stage Exchange Arthroplasty)
Withdrawn
- Prosthetic Joint Infection
- Phage Therapy
- Two-Stage Exchange Arthroplasty
-
Rochester, MinnesotaMayo Clinic
Mar 22, 2022
Osteomyelitis, Diabetic Foot Osteomyelitis Trial in United States (Phage Therapy, Placebo)
Recruiting
- Osteomyelitis
- Diabetic Foot Osteomyelitis
- Phage Therapy
- Placebo
-
Little Rock, Arkansas
- +4 more
Jul 29, 2022
Chronic Pseudomonas Aeruginosa Infection, Cystic Fibrosis Trial in Israel, United States (BX004-A, Placebo)
Recruiting
- Chronic Pseudomonas Aeruginosa Infection
- Cystic Fibrosis
- BX004-A
- Placebo
-
Hollywood, Florida
- +7 more
Jun 28, 2022
Bacterial Disease Carrier, Cystic Fibrosis Trial in United States (Placebo, WRAIR_PAM-CF1)
Recruiting
- Bacterial Disease Carrier
- Cystic Fibrosis
- Placebo
- WRAIR_PAM-CF1
-
La Jolla, California
- +14 more
Aug 11, 2022
Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection, Staphylococcus Aureus Infection Trial in Jerusalem, Tel Aviv (TP-102)
Recruiting
- Diabetic Foot Ulcer
- +3 more
- TP-102
-
Jerusalem, Israel
- +1 more
Jun 17, 2022
Diabetic Foot, Staphylococcal Infections Trial in France (Topical anti-Staphylococcus bacteriophage therapy, Topical
Not yet recruiting
- Diabetic Foot
- Staphylococcal Infections
- Topical anti-Staphylococcus bacteriophage therapy
- Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy
-
Bordeaux, France
- +8 more
Feb 2, 2022
Pressure Ulcer Trial (Bacteriophage-loaded Microcapsule Spray, Placebo, Standard of Care)
Not yet recruiting
- Pressure Ulcer
- Bacteriophage-loaded Microcapsule Spray
- +2 more
- (no location specified)
Dec 15, 2021
Wound Infection Trial (Bacteriophage cocktail spray, Xeroform)
Not yet recruiting
- Wound Infection
- Bacteriophage cocktail spray
- Xeroform
- (no location specified)
Dec 21, 2021
Recurrent Urinary Tract Infection Trial in Toronto (Phage Therapy)
Not yet recruiting
- Recurrent Urinary Tract Infection
- Phage Therapy
-
Toronto, Ontario, CanadaSt. Joseph's Health Centre
Sep 9, 2022
HIV Trial in Puerto Rico, United States (Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed, Diphtheria and
Completed
- HIV Infections
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
- +4 more
-
Long Beach, California
- +13 more
Oct 28, 2021
Avis-PHAGEinLYON Clinic
Recruiting
- Bone Infection
- Phage therapy requests
-
Lyon, FranceCentre de Référence des Infections Ostéo-Articulaires complexes
May 22, 2023
Bacteremia, Staphylococcus Aureus, Staphylococcus Aureus Bacteremia Trial in United States (AP-SA02, Placebo)
Recruiting
- Bacteremia
- +4 more
- AP-SA02
- Placebo
-
Detroit, Michigan
- +3 more
May 13, 2022
Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas Trial in United States (AP-PA02, Placebo)
Active, not recruiting
- Cystic Fibrosis
- +4 more
- AP-PA02
- Placebo
-
Los Angeles, California
- +19 more
Dec 20, 2022
Phage Safety Cohort Study
Recruiting
- Prosthetic Joint Infection
- Severe Infection
- Adverse event after injection of phages
-
Lyon, FranceHospices Civils de Lyon
May 20, 2022
Temporomandibular Joint Disorders, Extracorporeal Shockwave Therapy Trial in São Paulo (Focused Extracorporeal Shockwave
Recruiting
- Temporomandibular Joint Disorders
- Extracorporeal Shockwave Therapy
- Focused Extracorporeal Shockwave Therapy
- Placebo Focused Extracorporeal Shockwave Therapy
-
São Paulo, Sao Paulo, BrazilUniversity of São Paulo General Hospital
Jun 7, 2023
Covid19, Bacteremia, Septicemia Trial (Phage Therapy)
No longer available
- Covid19
- +5 more
- Phage Therapy
- (no location specified)
Dec 6, 2021
Transmission, Other/Miscellaneous Trial in Cleveland (Slippers)
Completed
- Transmission, Other/Miscellaneous
- Slippers
-
Cleveland, OhioCleveland VA Medical Center
Jun 24, 2021